NCT01664871View on ClinicalTrials.gov

Pharmacokinetics of Diammine Silver Fluoride

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

August 31, 2011

Study Completion Date

September 30, 2011

Conditions
Fluoride and Silver Pharmacokinetics of DSF Applied Topically to Teeth of Adults. Erythema, Bleeding, White Changes, Ulceration and Pigmentation Were Assessed
Interventions
DEVICE

DIammine SIlver Fluoride

Concentrations of Silver and Fluoride in the DSF used for study were 24.9% and 5.5%, respectively Average total weight (calculated volume) of Diammine Silver Fluoride applied was 7.57 mg (6.04 µL), corresponding to a mean application of 0.33 mg Fluoride based on the lot analysis. The mean total amount of Silver applied to the 3 teeth was 1.50 mg.

Trial Locations (1)

Unknown

Universidad Catolica Santa Maria, Arequipa

All Listed Sponsors
lead

Universidad Peruana Cayetano Heredia

OTHER

NCT01664871 - Pharmacokinetics of Diammine Silver Fluoride | Biotech Hunter | Biotech Hunter